tirzepatide ocular side effects Mounjaro Eye Lawsuit [2026 Update] RACGP - Semaglutide links to

Starting at $ 115 / Month GLP-1 receptor agonist that is FDA-approved for chronic weight management Wegovy Adults with obesity (BMI 30) or overweight (BMI 27 with a weight-related condition such as hypertension, diabetes, or high cholesterol) Start todayMore Info Potential Weight Loss* Administration methods** Injections Dose frequency*** Weekly Potential side effects Possible side effects may include nausea, vomiting, constipation, diarrhea, indigestion or stomach discomfort, reduced appetite, headache, fatigue, or injection site reactionsespecially when starting or increasing the dose

Can semaglutide help with other health conditions

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimers diseaseis this type 3 diabetes

Because GLP-1 medications slow gastric emptying, they can potentially affect the absorption of oral hormone therapy

Practical supports are the ones that let you detect change early: Frequent weight checks Simple glucose logs if relevant Short follow-up visits in the first few weeks Clinicians may discuss alternative options such as different GLP-1 agents or combination therapies if weight or glucose control slips